l carnitine 5g injection Frontiers Levocarnitine / Products / American

developed a quantitative systems pharmacology model to evaluate VPAinduced hyperammonaemia and used this model to evaluate the use of Lcarnitine in preventing hyperammonaemia in both chronic and acute VPA toxicity

The study was conducted in accordance with the standards of the Declaration of Helsinki and was approved by the ethics committee of the Freiburger Ethik-Kommission International (FEKI, feki Code: 016/1224)

Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration

These cytokines recruit additional immune cells and amplify liver inflammation, exacerbating tissue injury

European Journal of Clinical Pharmacology, 66: 427428